Life Science REIT PLC (LSE:LABS) — Stock Price
Life Science REIT PLC (LSE:LABS) is currently trading at GBX43.10 GBX, up 0.00% today. Over the past 52 weeks, shares have ranged between GBX35.40 and GBX44.00. This page tracks Life Science REIT PLC's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Life Science REIT PLC market cap and net worth.
Life Science REIT PLC (LABS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Life Science REIT PLC's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Life Science REIT PLC Income Statement — Revenue, Profit & Earnings by Year
Life Science REIT PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | GBX20.31 Million | GBX19.94 Million | GBX-19.92 Million | GBX8.12 Million |
| Cost of Revenue | GBX8.86 Million | GBX9.51 Million | GBX8.56 Million | GBX455.00K |
| Gross Profit | GBX11.45 Million | GBX10.44 Million | GBX-19.92 Million | GBX8.12 Million |
| Research & Development | — | — | — | — |
| SG&A | GBX7.71 Million | GBX7.98 Million | GBX7.55 Million | GBX379.00K |
| Total Operating Expenses | GBX28.10 Million | GBX34.53 Million | GBX7.55 Million | GBX379.00K |
| Operating Income | GBX9.78 Million | GBX-14.59 Million | GBX-27.47 Million | GBX7.74 Million |
| EBITDA | GBX9.78 Million | GBX8.72 Million | GBX-27.47 Million | GBX7.74 Million |
| EBIT | — | GBX28.08 Million | GBX-27.47 Million | GBX7.74 Million |
| Interest Expense | GBX9.22 Million | GBX11.07 Million | GBX3.78 Million | GBX0.00 |
| Income Before Tax | GBX-13.98 Million | GBX-21.85 Million | GBX-27.47 Million | GBX7.74 Million |
| Income Tax Expense | — | GBX-146.00K | GBX146.00K | GBX7.32 Million |
| Net Income | GBX-13.98 Million | GBX-21.71 Million | GBX-27.61 Million | GBX7.74 Million |
Life Science REIT PLC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Life Science REIT PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | GBX401.19 Million | GBX410.70 Million | GBX447.82 Million | GBX361.40 Million |
| Total Current Assets | GBX5.57 Million | GBX14.34 Million | GBX20.97 Million | GBX166.94 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | GBX7.84 Million | GBX10.06 Million | GBX10.37 Million | GBX982.00K |
| Inventory | — | — | GBX55.97 Million | GBX167.84 Million |
| Property, Plant & Equipment | — | — | — | GBX192.17 Million |
| Goodwill | — | — | — | — |
| Total Liabilities | GBX138.42 Million | GBX126.96 Million | GBX128.37 Million | GBX10.82 Million |
| Total Current Liabilities | — | GBX1.82 Million | GBX1.03 Million | GBX1.52 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | GBX116.67 Million | GBX93.58 Million | GBX99.22 Million | GBX-165.96 Million |
| Total Stockholder Equity | GBX262.77 Million | GBX283.75 Million | GBX319.45 Million | GBX350.58 Million |
| Retained Earnings | GBX-55.55 Million | GBX-41.58 Million | GBX-19.87 Million | GBX7.74 Million |
Life Science REIT PLC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Life Science REIT PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | GBX12.92 Million | GBX7.62 Million | GBX-1.09 Million | GBX3.54 Million |
| Capital Expenditures | GBX19.28 Million | GBX24.03 Million | GBX7.64 Million | GBX7.64 Million |
| Free Cash Flow | GBX-6.36 Million | GBX-16.42 Million | GBX-1.09 Million | GBX3.54 Million |
| Investing Cash Flow | GBX-16.35 Million | GBX-11.64 Million | GBX-186.38 Million | GBX-181.52 Million |
| Financing Cash Flow | GBX-5.34 Million | GBX-27.24 Million | GBX67.11 Million | GBX343.94 Million |
| Dividends Paid | GBX-7.00 Million | GBX-14.00 Million | GBX3.50 Million | GBX0.00 |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | — | — | — | — |
| Change in Cash | GBX-8.77 Million | GBX-31.27 Million | GBX-120.36 Million | GBX165.96 Million |
Life Science REIT PLC Earnings History — EPS Actual vs. Analyst Estimates
Track Life Science REIT PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 23, 2025 | 0.01 | 0.00 | — |
| Apr 16, 2025 | 0.00 | 0.00 | — |
| Mar 27, 2023 | -0.10 | 0.00 | — |
| Sep 22, 2022 | 0.02 | 0.00 | — |